61 related articles for article (PubMed ID: 38542506)
21. FFPE-Based NGS Approaches into Clinical Practice: The Limits of Glory from a Pathologist Viewpoint.
Cappello F; Angerilli V; Munari G; Ceccon C; Sabbadin M; Pagni F; Fusco N; Malapelle U; Fassan M
J Pers Med; 2022 May; 12(5):. PubMed ID: 35629172
[TBL] [Abstract][Full Text] [Related]
22. Concordance of Peripheral Blood and Bone Marrow Next-Generation Sequencing in Hematologic Neoplasms.
Jumniensuk C; Nobori A; Lee T; Senaratne TN; Rao D; Pullarkat S
Adv Hematol; 2022; 2022():8091746. PubMed ID: 35378848
[TBL] [Abstract][Full Text] [Related]
23. Challenges in the application of NGS in the clinical laboratory.
Yin Y; Butler C; Zhang Q
Hum Immunol; 2021 Nov; 82(11):812-819. PubMed ID: 33892986
[TBL] [Abstract][Full Text] [Related]
24. Ultradeep targeted sequencing reveals low allele frequencies of somatic JAK2 and MPL variants in patients with abdominal vein thromboses: results of an ongoing prospective prevalence study in Mecklenburg-West Pomerania.
Grunwald L; Grosse-Thie C; Sender S; Knuebel G; Krohn S; Roolf C; Junghanss C; Henze L; Murua Escobar H
Biomark Res; 2020 Dec; 8(1):73. PubMed ID: 33317584
[TBL] [Abstract][Full Text] [Related]
25. Single-molecule DNA sequencing of widely varying GC-content using nucleotide release, capture and detection in microdroplets.
Puchtler TJ; Johnson K; Palmer RN; Talbot EL; Ibbotson LA; Powalowska PK; Knox R; Shibahara A; M S Cunha P; Newell OJ; Wu M; Chana J; Athanasopoulou EN; Waeber AM; Stolarek M; Silva AL; Mordaka JM; Haggis-Powell M; Xyrafaki C; Bush J; Topkaya IS; Sosna M; Ingham RJ; Huckvale T; Negrea A; Breiner B; Šlikas J; Kelly DJ; Dunning AJ; Bell NM; Dethlefsen M; Love DM; Dear PH; Kuleshova J; Podd GJ; Isaac TH; Balmforth BW; Frayling CA
Nucleic Acids Res; 2020 Dec; 48(22):e132. PubMed ID: 33152076
[TBL] [Abstract][Full Text] [Related]
26. Mutational analysis of hematologic neoplasms in 164 paired peripheral blood and bone marrow samples by next-generation sequencing.
Lucas F; Michaels PD; Wang D; Kim AS
Blood Adv; 2020 Sep; 4(18):4362-4365. PubMed ID: 32926123
[TBL] [Abstract][Full Text] [Related]
27. Why Formalin-fixed, Paraffin-embedded Biospecimens Must Be Used in Genomic Medicine: An Evidence-based Review and Conclusion.
Mathieson W; Thomas GA
J Histochem Cytochem; 2020 Aug; 68(8):543-552. PubMed ID: 32697619
[TBL] [Abstract][Full Text] [Related]
28. Nanopore Sequencing in Blood Diseases: A Wide Range of Opportunities.
Minervini CF; Cumbo C; Orsini P; Anelli L; Zagaria A; Specchia G; Albano F
Front Genet; 2020; 11():76. PubMed ID: 32140171
[TBL] [Abstract][Full Text] [Related]
29. Use of FFPE-derived DNA in next generation sequencing: DNA extraction methods.
McDonough SJ; Bhagwate A; Sun Z; Wang C; Zschunke M; Gorman JA; Kopp KJ; Cunningham JM
PLoS One; 2019; 14(4):e0211400. PubMed ID: 30973937
[TBL] [Abstract][Full Text] [Related]
30. Early detection and monitoring of cancer in liquid biopsy: advances and challenges.
Xue VW; Wong CSC; Cho WCS
Expert Rev Mol Diagn; 2019 Apr; 19(4):273-276. PubMed ID: 30760042
[No Abstract] [Full Text] [Related]
31. MDS overlap disorders and diagnostic boundaries.
Tanaka TN; Bejar R
Blood; 2019 Mar; 133(10):1086-1095. PubMed ID: 30670443
[TBL] [Abstract][Full Text] [Related]
32. Targeted deep sequencing in primary myelofibrosis.
Tefferi A; Lasho TL; Finke CM; Elala Y; Hanson CA; Ketterling RP; Gangat N; Pardanani A
Blood Adv; 2016 Dec; 1(2):105-111. PubMed ID: 29296803
[TBL] [Abstract][Full Text] [Related]
33. Review of Clinical Next-Generation Sequencing.
Yohe S; Thyagarajan B
Arch Pathol Lab Med; 2017 Nov; 141(11):1544-1557. PubMed ID: 28782984
[TBL] [Abstract][Full Text] [Related]
34. Guidelines for Validation of Next-Generation Sequencing-Based Oncology Panels: A Joint Consensus Recommendation of the Association for Molecular Pathology and College of American Pathologists.
Jennings LJ; Arcila ME; Corless C; Kamel-Reid S; Lubin IM; Pfeifer J; Temple-Smolkin RL; Voelkerding KV; Nikiforova MN
J Mol Diagn; 2017 May; 19(3):341-365. PubMed ID: 28341590
[TBL] [Abstract][Full Text] [Related]
35. Precision oncology for acute myeloid leukemia using a knowledge bank approach.
Gerstung M; Papaemmanuil E; Martincorena I; Bullinger L; Gaidzik VI; Paschka P; Heuser M; Thol F; Bolli N; Ganly P; Ganser A; McDermott U; Döhner K; Schlenk RF; Döhner H; Campbell PJ
Nat Genet; 2017 Mar; 49(3):332-340. PubMed ID: 28092685
[TBL] [Abstract][Full Text] [Related]
36. Deamination Effects in Formalin-Fixed, Paraffin-Embedded Tissue Samples in the Era of Precision Medicine.
Kim S; Park C; Ji Y; Kim DG; Bae H; van Vrancken M; Kim DH; Kim KM
J Mol Diagn; 2017 Jan; 19(1):137-146. PubMed ID: 27840062
[TBL] [Abstract][Full Text] [Related]
37. Inter-Laboratory Evaluation of a Next-Generation Sequencing Panel for Acute Myeloid Leukemia.
Haslam K; Catherwood MA; Dobbin E; Sproul A; Langabeer SE; Mills KI
Mol Diagn Ther; 2016 Oct; 20(5):457-61. PubMed ID: 27342108
[TBL] [Abstract][Full Text] [Related]
38. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia.
Arber DA; Orazi A; Hasserjian R; Thiele J; Borowitz MJ; Le Beau MM; Bloomfield CD; Cazzola M; Vardiman JW
Blood; 2016 May; 127(20):2391-405. PubMed ID: 27069254
[TBL] [Abstract][Full Text] [Related]
39. Targeted next-generation sequencing of locally advanced squamous cell carcinomas of the head and neck reveals druggable targets for improving adjuvant chemoradiation.
Tinhofer I; Budach V; Saki M; Konschak R; Niehr F; Jöhrens K; Weichert W; Linge A; Lohaus F; Krause M; Neumann K; Endris V; Sak A; Stuschke M; Balermpas P; Rödel C; Avlar M; Grosu AL; Abdollahi A; Debus J; Belka C; Pigorsch S; Combs SE; Mönnich D; Zips D; Baumann M;
Eur J Cancer; 2016 Apr; 57():78-86. PubMed ID: 26896955
[TBL] [Abstract][Full Text] [Related]
40. Clinical evaluation of panel testing by next-generation sequencing (NGS) for gene mutations in myeloid neoplasms.
Au CH; Wa A; Ho DN; Chan TL; Ma ES
Diagn Pathol; 2016 Jan; 11():11. PubMed ID: 26796102
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
